Delivery Order SPE2DR25D6028-SPE2DR26FATVF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,693.53 to AmerisourceBergen Drug Corp for ProQuad vials on December 9, 2025, with a completion date of December 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, supporting the military...
- The Defense Logistics Agency awarded a $13,367.20 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on September 16, 2025, with an ultimate completion date of October 7, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.91 to AmerisourceBergen Drug Corp for ProQuad vials on October 29, 2025, with completion scheduled by November 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, supporting the federal government's immunization and...
- The Defense Logistics Agency awarded a delivery order valued at $13,499.84 to AmerisourceBergen Drug Corp for ProQuad vials on August 25, 2025, with completion targeted for September 16, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunity against measles, mumps, rubella, and varicella, making this order part of the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for ProQuad vials with a ceiling value of $1,687.48 and a firm fixed price structure. The contract is scheduled for ultimate completion by August 6, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $3,374.96 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization protection against measles, mumps, rubella, and varicella, commonly used within military and federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a $3,341.80 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on June 20, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $2,616.85 to AmerisourceBergen Drug Corp for ProQuad vials on December 8, 2025, with completion expected by December 30, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used to prevent measles, mumps, rubella, and varicella, making this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,654.33 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, making this...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FATVFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 17, 2026, for ProQuad Vials in quantities of 10 units, with a ceiling value of $3,792.70 and an ultimate completion date of February 5, 2026. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, critical for military personnel and beneficiaries within the Defense Health Agency system. The DLA Troop Support Medical contract under which this delivery order falls enables flexible procurement of pharmaceutical products and medical supplies across multiple therapeutic domains to support military treatment facilities and veterans' healthcare programs worldwide. AmerisourceBergen's extensive experience fulfilling federal medical procurement requirements and its designation as a prime vendor for pharmaceutical commodities underscore its capability to supply this essential vaccine for military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 1/16/26 |